Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.

Reliable and reproducible methods for the measurements of artemisinin and its derivatives in body fluids have proved difficult to develop. The available evidence suggests that all compounds are hydrolysed to a biologically active metabolite, dihydroartemisinin, which is eliminated rapidly. The role...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	White, N
Format:	Conference item
Wydane:	1994

Podobne zapisy

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
od: Lohy Das, J, i wsp.
Wydane: (2017)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
od: André Daher, i wsp.
Wydane: (2019-09-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
od: White, N, i wsp.
Wydane: (1999)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
od: White, N, i wsp.
Wydane: (1999)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
od: Das, J, i wsp.
Wydane: (2018)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
od: Jesmin Permala Lohy Das, i wsp.
Wydane: (2018-03-01)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
od: White, N
Wydane: (2013)

Pharmacokinetics and pharmacodynamics of curcumin.
od: Sharma, R, i wsp.
Wydane: (2007)

Intrarectal artemisinin derivatives.
od: Nosten, F, i wsp.
Wydane: (1998)

Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication
od: José Osvaldo Barbosa Neto, i wsp.

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
od: Hirsh Elhence, i wsp.
Wydane: (2022-12-01)

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
od: Ezzet, F, i wsp.
Wydane: (2000)

Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.
od: Pukrittayakamee, S, i wsp.
Wydane: (2003)

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
od: Simpson, J, i wsp.
Wydane: (2000)

Safety, pharmacokinetics and efficacy of artemisinins in pregnancy
od: Veronica Ades
Wydane: (2011-05-01)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
od: Abd. Rahman, Nurul Azrin, i wsp.
Wydane: (2013)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
od: Vadim Valer'evich Klimontov, i wsp.
Wydane: (2014-12-01)

Pharmacokinetic-pharmacodynamic modeling and simulation /
od: 192959 Bonate, Peter L.
Wydane: (2005)

Pharmacodynamics and pharmacokinetics of snake antivenom
od: Bhagya Nikapitiya, i wsp.
Wydane: (2018-06-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
od: Susanna Burckhardt, i wsp.
Wydane: (2011-01-01)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
od: Longfei Zhang, i wsp.
Wydane: (2022-03-01)

Artemisinin and derivatives in the treatment of uncomplicated malaria.
od: White, N, i wsp.
Wydane: (1998)

Use of artemisinin derivatives for the control of malaria.
od: Nosten, F, i wsp.
Wydane: (1998)

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
od: Randall, Elizabeth C., i wsp.
Wydane: (2019)

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
od: Elizabeth C. Randall, i wsp.
Wydane: (2018-11-01)

Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
od: Chierakul, W, i wsp.
Wydane: (2006)

Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of danofloxacin in Lohi sheep
od: Z. Manzoor, i wsp.
Wydane: (2020-12-01)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
od: Jamsen, K, i wsp.
Wydane: (2012)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
od: Roganović Maša, i wsp.
Wydane: (2021-01-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Pharmacokinetic-pharmacodynamic assessment of the safety of fexinidazole for the treatment of human African trypanosomiasis
od: Watson, J, i wsp.
Wydane: (2018)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
od: Lees, Peter, i wsp.
Wydane: (2003)

Zopiclone: some remarks on pharmacokinetics and pharmacodynamics
od: Swiss Medical Weekly
Wydane: (2003-02-01)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
od: Andrzej Czyrski, i wsp.
Wydane: (2021-11-01)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
od: Koen G. A. M. Hussaarts, i wsp.
Wydane: (2020-08-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
od: Mercè Brunet, i wsp.
Wydane: (2022-08-01)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
od: Jeff D. Olivarez, i wsp.
Wydane: (2023-01-01)

Pharmacokinetics and Pharmacodynamics of Anaesthetic drugs in Paediatrics
od: Rebecca Jacob, i wsp.
Wydane: (2004-01-01)

Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
od: Anca Dragomirescu,, i wsp.
Wydane: (2008-12-01)